Dusk And Dawn In Emerging Markets? Pharmas Find Growth Elsewhere Offset Turkish Price Cuts
This article was originally published in PharmAsia News
Executive Summary
Each market is different, but even more so in emerging markets. The world's sixth-largest drug maker Novartis' first quarter results showed that strong growth from top pharmemerging markets, China, India, Brazil, and South Korea "more than" offset an across-the-board drug price cut in Turkey